BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

19 articles for EA Peterson

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Sulfonamides as Selective NaEBI
Amgen
Sulfonamides as Selective NaEBI
Amgen
Sulfonamides as Selective NaEBI
Amgen
Discovery of (R)-6-(1-(8-Fluoro-6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one (AMG 337), a Potent and Selective Inhibitor of MET with High Unbound Target Coverage and Robust In Vivo Antitumor Activity.EBI
Amgen
Discovery of potent and selective 8-fluorotriazolopyridine c-Met inhibitors.EBI
Amgen
Discovery and optimization of potent and selective imidazopyridine and imidazopyridazine mTOR inhibitors.EBI
Amgen
Discovery of triazine-benzimidazoles as selective inhibitors of mTOR.EBI
Amgen
A Tiny Pocket Packs a Punch: Leveraging Pyridones for the Discovery of CNS-Penetrant Aza-indazole IRAK4 Inhibitors.EBI
Biogen
The Discovery of 7-Isopropoxy-2-(1-methyl-2-oxabicyclo[2.1.1]hexan-4-yl)-N-(6-methylpyrazolo[1,5-a]pyrimidin-3-yl)imidazo[1,2-a]pyrimidine-6-carboxamide (BIO-7488), a Potent, Selective, and CNS-Penetrant IRAK4 Inhibitor for the Treatment of Ischemic Stroke.EBI
Biogen
Discovery of BIO-8169─A Highly Potent, Selective, and Brain-Penetrant IRAK4 Inhibitor for the Treatment of Neuroinflammation.EBI
Biogen Inc.
Discovery of Phospholipase D Inhibitors with Improved Drug-like Properties and Central Nervous System Penetrance.EBI
Biogen
1,2,4-Triazolsulfone: A novel isosteric replacement of acylsulfonamides in the context of NaEBI
Amgen
Discovery of a biarylamide series of potent, state-dependent NaEBI
Amgen
The discovery of benzoxazine sulfonamide inhibitors of NaEBI
Amgen
Benzo[5,6][1,4]dioxino[2,3-b]pyridine compounds useful as IRAK4 inhibitorsBDB
Bristol-Myers Squibb
NEW SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORSBDB
Boehringer Ingelheim International
Substituted 3-haloallylamine inhibitors of ASSAO and uses thereofBDB
Boehringer Ingelheim International
Effect of N-methyl substitution of the peptide bonds in luteinizing hormone-releasing hormone agonists.BDB
Abbott Laboratories